These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 6959604

  • 1. Doxorubicin and hyperpigmentation.
    Alagaratnam TT, Choi TK, Ong GB.
    Aust N Z J Surg; 1982 Oct; 52(5):531-3. PubMed ID: 6959604
    [No Abstract] [Full Text] [Related]

  • 2. [Nail hyperpigmentation as a secondary effect of doxorubicin].
    Sanz Ortiz J, Méndez Batán MA, Fariñas Alvarez C, Gutiérrez del Río C.
    Med Clin (Barc); 1982 Jun 01; 79(1):49-50. PubMed ID: 7121110
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pigmentation with doxorubicin therapy.
    Orr LE, McKernan JF.
    Arch Dermatol; 1980 Mar 01; 116(3):273. PubMed ID: 6245620
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nail pigmentation following cancer chemotherapy. A new genetic entity?
    Sulis E, Floris C.
    Eur J Cancer (1965); 1980 Nov 01; 16(11):1517-9. PubMed ID: 6453014
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of pigmentary side effects of taxanes and anthracyclines: an onychoscopic evaluation.
    Yorulmaz A, Dogan M, Artuz F, Zengin N.
    Cutan Ocul Toxicol; 2017 Jun 01; 36(2):135-139. PubMed ID: 27086693
    [Abstract] [Full Text] [Related]

  • 8. Nail and mucocutaneous hyperpigmentation with azidothymidine therapy.
    Greenberg RG, Berger TG.
    J Am Acad Dermatol; 1990 Feb 01; 22(2 Pt 2):327-30. PubMed ID: 2303586
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Minocycline hyperpigmentation: skin, tooth, nail, and bone involvement.
    Wolfe ID, Reichmister J.
    Cutis; 1984 May 01; 33(5):457-8. PubMed ID: 6478869
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Doxorubicin induced melanonychia.
    M I, Khairkar PH.
    Indian Pediatr; 2003 Nov 01; 40(11):1094-5. PubMed ID: 14660845
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Doxorubicin induced hyperpigmentation.
    Kumar L, Kochupillai V.
    N Z Med J; 1990 Apr 11; 103(887):165. PubMed ID: 2342686
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mitoxantrone induced hyperpigmentation.
    Kumar L, Kochipillai V.
    N Z Med J; 1990 Feb 14; 103(883):55. PubMed ID: 2304701
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.